Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Journal of Thoracic Oncology
Publication status	Published - 2022
Event	IASLC 2022 World Conference on Lung Cancer - Vienna, Austria Duration: 6 Aug 2022 → 9 Aug 2022

Branches of science

Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients
Hochmair, M. (Author), Absenger, G. (Author), Ay, L. (Author), Robinson, I. (Author), Jansen, C. (Author), Sladek, B. (Author), Knabl, A. (Author), Gasche, N. (Author) & Valipou, A. (Author)
2022
Activity: Talk, presentation or poster › Poster

@article{fc68483d858247cca94b9138bfec6152,

title = "Introducing {"}BiomeOne{"} a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients",

author = "M Hochmair and Gudrun Absenger and L Ay and I Robinson and C Jansen and B Sladek and A Knabl and N Gasche and A Valipou",

year = "2022",

language = "English",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

note = "IASLC 2022 World Conference on Lung Cancer ; Conference date: 06-08-2022 Through 09-08-2022",

}

TY - JOUR

T1 - Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients

AU - Hochmair, M

AU - Absenger, Gudrun

AU - Ay, L

AU - Robinson, I

AU - Jansen, C

AU - Sladek, B

AU - Knabl, A

AU - Gasche, N

AU - Valipou, A

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000858678101461

M3 - Conference abstract

SN - 1556-0864

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

T2 - IASLC 2022 World Conference on Lung Cancer

Y2 - 6 August 2022 through 9 August 2022

ER -